GERRESHEIMER AG (GXI.DE) Stock Fundamental Analysis
FRA:GXI - DE000A0LD6E6 - Common Stock
41.24 EUR
-0.68 (-1.62%)
Overall GXI gets a fundamental rating of 3 out of 10. We evaluated GXI against 18 industry peers in the Life Sciences Tools & Services industry. GXI may be in some trouble as it scores bad on both profitability and health. GXI has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year GXI was profitable.
GXI had a positive operating cash flow in the past year.
In the past 5 years GXI has always been profitable.
Each year in the past 5 years GXI had a positive operating cash flow.
1.2 Ratios
With a Return On Assets value of 1.33%, GXI is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
The Return On Equity of GXI (4.39%) is worse than 66.67% of its industry peers.
GXI's Return On Invested Capital of 3.59% is on the low side compared to the rest of the industry. GXI is outperformed by 72.22% of its industry peers.
GXI had an Average Return On Invested Capital over the past 3 years of 6.14%. This is in line with the industry average of 7.23%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.33% | ||
| ROE | 4.39% | ||
| ROIC | 3.59% |
ROA(3y)3.04%
ROA(5y)3.09%
ROE(3y)7.67%
ROE(5y)8.3%
ROIC(3y)6.14%
ROIC(5y)6.08%
1.3 Margins
With a Profit Margin value of 2.89%, GXI is not doing good in the industry: 77.78% of the companies in the same industry are doing better.
In the last couple of years the Profit Margin of GXI has remained more or less at the same level.
GXI's Operating Margin of 8.03% is on the low side compared to the rest of the industry. GXI is outperformed by 66.67% of its industry peers.
In the last couple of years the Operating Margin of GXI has grown nicely.
GXI has a worse Gross Margin (28.07%) than 66.67% of its industry peers.
GXI's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.03% | ||
| PM (TTM) | 2.89% | ||
| GM | 28.07% |
OM growth 3Y-0.21%
OM growth 5Y2.69%
PM growth 3Y-1.23%
PM growth 5Y-1.47%
GM growth 3Y0.37%
GM growth 5Y1.38%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so GXI is destroying value.
GXI has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, GXI has more shares outstanding
The debt/assets ratio for GXI is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 1.06, we must say that GXI is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.06, GXI is doing worse than 77.78% of the companies in the same industry.
A Debt/Equity ratio of 1.18 is on the high side and indicates that GXI has dependencies on debt financing.
GXI has a worse Debt to Equity ratio (1.18) than 77.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.18 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.06 |
ROIC/WACC0.46
WACC7.79%
2.3 Liquidity
A Current Ratio of 1.01 indicates that GXI should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.01, GXI is doing worse than 88.89% of the companies in the same industry.
A Quick Ratio of 0.56 indicates that GXI may have some problems paying its short term obligations.
GXI has a worse Quick ratio (0.56) than 88.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.01 | ||
| Quick Ratio | 0.56 |
3. Growth
3.1 Past
The earnings per share for GXI have decreased by -7.16% in the last year.
GXI shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -8.23% yearly.
Looking at the last year, GXI shows a quite strong growth in Revenue. The Revenue has grown by 9.32% in the last year.
The Revenue has been growing slightly by 7.90% on average over the past years.
EPS 1Y (TTM)-7.16%
EPS 3Y4.26%
EPS 5Y-8.23%
EPS Q2Q%-27.42%
Revenue 1Y (TTM)9.32%
Revenue growth 3Y10.77%
Revenue growth 5Y7.9%
Sales Q2Q%19.57%
3.2 Future
Based on estimates for the next years, GXI will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.93% on average per year.
Based on estimates for the next years, GXI will show a quite strong growth in Revenue. The Revenue will grow by 8.96% on average per year.
EPS Next Y-17.61%
EPS Next 2Y1.51%
EPS Next 3Y7.75%
EPS Next 5Y9.93%
Revenue Next Year17.92%
Revenue Next 2Y12.08%
Revenue Next 3Y10.37%
Revenue Next 5Y8.96%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 9.94, the valuation of GXI can be described as reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of GXI indicates a rather cheap valuation: GXI is cheaper than 100.00% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of GXI to the average of the S&P500 Index (27.06), we can say GXI is valued rather cheaply.
A Price/Forward Earnings ratio of 8.55 indicates a reasonable valuation of GXI.
Based on the Price/Forward Earnings ratio, GXI is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of GXI to the average of the S&P500 Index (22.69), we can say GXI is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.94 | ||
| Fwd PE | 8.55 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, GXI is valued cheaper than 94.44% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 8.25 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.51%
EPS Next 3Y7.75%
5. Dividend
5.1 Amount
With a yearly dividend of 0.10%, GXI is not a good candidate for dividend investing.
GXI's Dividend Yield is slightly below the industry average, which is at 0.73.
With a Dividend Yield of 0.10, GXI pays less dividend than the S&P500 average, which is at 2.41.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.1% |
5.2 History
The dividend of GXI has a limited annual growth rate of 0.94%.
Dividend Growth(5Y)0.94%
Div Incr Years0
Div Non Decr Years6
5.3 Sustainability
69.83% of the earnings are spent on dividend by GXI. This is not a sustainable payout ratio.
The dividend of GXI is growing, but earnings are growing more, so the dividend growth is sustainable.
DP69.83%
EPS Next 2Y1.51%
EPS Next 3Y7.75%
FRA:GXI (9/5/2025, 7:00:00 PM)
41.24
-0.68 (-1.62%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners87.13%
Inst Owner ChangeN/A
Ins Owners4.92%
Ins Owner ChangeN/A
Market Cap1.42B
Analysts73.33
Price Target66.03 (60.11%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.1% |
Yearly Dividend1.32
Dividend Growth(5Y)0.94%
DP69.83%
Div Incr Years0
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.55%
Min EPS beat(2)-6.69%
Max EPS beat(2)17.79%
EPS beat(4)2
Avg EPS beat(4)6.98%
Min EPS beat(4)-6.69%
Max EPS beat(4)18.84%
EPS beat(8)4
Avg EPS beat(8)3.56%
EPS beat(12)7
Avg EPS beat(12)3.1%
EPS beat(16)8
Avg EPS beat(16)1.87%
Revenue beat(2)0
Avg Revenue beat(2)-1.22%
Min Revenue beat(2)-1.59%
Max Revenue beat(2)-0.85%
Revenue beat(4)0
Avg Revenue beat(4)-1.1%
Min Revenue beat(4)-1.59%
Max Revenue beat(4)-0.72%
Revenue beat(8)1
Avg Revenue beat(8)-1%
Revenue beat(12)4
Avg Revenue beat(12)-0.6%
Revenue beat(16)6
Avg Revenue beat(16)-0.15%
PT rev (1m)-1.54%
PT rev (3m)-30.41%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-26.82%
EPS NY rev (3m)-26.82%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.87%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.94 | ||
| Fwd PE | 8.55 | ||
| P/S | 0.65 | ||
| P/FCF | N/A | ||
| P/OCF | 5.95 | ||
| P/B | 0.99 | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.25 |
EPS(TTM)4.15
EY10.06%
EPS(NY)4.82
Fwd EY11.69%
FCF(TTM)-3.34
FCFYN/A
OCF(TTM)6.93
OCFY16.8%
SpS63.35
BVpS41.69
TBVpS-8.72
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.33% | ||
| ROE | 4.39% | ||
| ROCE | 4.85% | ||
| ROIC | 3.59% | ||
| ROICexc | 3.81% | ||
| ROICexgc | 7.75% | ||
| OM | 8.03% | ||
| PM (TTM) | 2.89% | ||
| GM | 28.07% | ||
| FCFM | N/A |
ROA(3y)3.04%
ROA(5y)3.09%
ROE(3y)7.67%
ROE(5y)8.3%
ROIC(3y)6.14%
ROIC(5y)6.08%
ROICexc(3y)6.5%
ROICexc(5y)6.42%
ROICexgc(3y)14.47%
ROICexgc(5y)16.32%
ROCE(3y)8.29%
ROCE(5y)8.2%
ROICexcg growth 3Y-17.1%
ROICexcg growth 5Y-18.13%
ROICexc growth 3Y-1.3%
ROICexc growth 5Y1.06%
OM growth 3Y-0.21%
OM growth 5Y2.69%
PM growth 3Y-1.23%
PM growth 5Y-1.47%
GM growth 3Y0.37%
GM growth 5Y1.38%
F-Score4
Asset Turnover0.46
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.18 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 4.13 | ||
| Cap/Depr | 149.83% | ||
| Cap/Sales | 16.21% | ||
| Interest Coverage | 2.39 | ||
| Cash Conversion | 58.03% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.01 | ||
| Quick Ratio | 0.56 | ||
| Altman-Z | 1.06 |
F-Score4
WACC7.79%
ROIC/WACC0.46
Cap/Depr(3y)167.14%
Cap/Depr(5y)152.09%
Cap/Sales(3y)15.92%
Cap/Sales(5y)14.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7.16%
EPS 3Y4.26%
EPS 5Y-8.23%
EPS Q2Q%-27.42%
EPS Next Y-17.61%
EPS Next 2Y1.51%
EPS Next 3Y7.75%
EPS Next 5Y9.93%
Revenue 1Y (TTM)9.32%
Revenue growth 3Y10.77%
Revenue growth 5Y7.9%
Sales Q2Q%19.57%
Revenue Next Year17.92%
Revenue Next 2Y12.08%
Revenue Next 3Y10.37%
Revenue Next 5Y8.96%
EBIT growth 1Y-16.38%
EBIT growth 3Y10.54%
EBIT growth 5Y10.8%
EBIT Next Year139.92%
EBIT Next 3Y43.59%
EBIT Next 5Y24.71%
FCF growth 1Y-73.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y16.98%
OCF growth 3Y4.26%
OCF growth 5Y4.49%